Table 2.
Methodological Index for Non-Randomized Studies scores for included non-randomized controlled trials
| MINORS checklist | Guo et al. [19] | Huang et al. [20] |
|---|---|---|
| A clearly stated aim | 2 | 2 |
| Inclusion of consecutive patients | 2 | 2 |
| Prospective collection of data | 2 | 2 |
| Endpoints appropriate to the aim of the study | 2 | 2 |
| Unbiased assessment of the study endpoint | 1 | 1 |
| Follow-up period appropriate to the aim of the study | 2 | 2 |
| Loss to follow up less than 5% | 2 | 2 |
| Prospective calculation of the study size | 0 | 0 |
| An adequate control group | 2 | 2 |
| Contemporary groups | 2 | 2 |
| Baseline equivalence of groups | 2 | 2 |
| Adequate statistical analyses | 2 | 2 |
| Total | 21 | 21 |
0–16: poor research quality; 17–20: fair research quality; 21–24: high research quality